Skip to main content

Table 2 Overview of patient instruments per time point (months)

From: Optimizing psychotherapy dosage for comorbid depression and personality disorders (PsyDos): a pragmatic randomized factorial trial using schema therapy and short-term psychodynamic psychotherapy

Instruments/months

I

A

0

1

2

3

6

END

FU 6 m

FU 12 m

Clinical outcomes

Depression

 BDI-II

 

X

X

X

X

X

X

X

X

X

 MINI plus, section A/B

 

X

     

X

 

X

Personality

 SIPP

X

    

Xa

X

X

X

 

 SCID-screener

X

      

X

 

X

 SCID-II / SCID-5-PD

 

X

     

X

 

X

 YSQ-sf

  

X

  

Xb

X

X

 

X

 SMI

  

X

  

Xc

X

X

 

X

 DPI

  

X

   

X

X

 

X

Quality of life

 EQ-5D(5 L)

  

X

  

X

X

X

 

X

 Happiness question

  

X

X

X

X

X

X

X

X

Cost-effectiveness

 Trimbos/iMTA Tic-P

  

X

   

X

X

X

X

Process/Predictors

 WAI-S

   

X

X

X

X

X

  

Other measures

 Demografics

X

         

 Treatment history

  

X

       

 BSI

X

 

X

  

X

X

X

 

X

 OQ-45

X

    

X

X

X

 

X

  1. I Intake, A Assessment, 0 Start of therapy, 1/2/3/6 Months in therapy, END End of therapy (at 8–12 months), FU 6 m Follow-up at 6 month after end of therapy, FU 12 Follow up at 12 months after end of therapy. aSIPP subscale Relational Capacities, bYSQ-sf subscales Emotional Deprivation and Failure, cSMI subscales Healthy Adult, Happy Child and Detached Protector